Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats
May 01, 2018 09:00 ET
|
Vivos Inc.
Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma. Five cats were treated at Washington...
Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board
March 20, 2018 09:30 ET
|
Vivos Inc.
Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board. Tariq Shah BSc. DipMS is the...
Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy
January 30, 2018 09:00 ET
|
Vivos Inc.
Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the FDA that RadioGel™ is classified as a device for animal therapy. ...
Vivos Completes Planned Dosing Schedule for Feline Sarcoma Program
January 12, 2018 11:54 ET
|
Vivos Inc.
Richland, WA, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has completed its planned dosing schedule to determine the effectiveness of using the Company’s...
Advanced Medical Isotope Corporation (ADMD) Announces Corporate Name Change to Vivos Inc., and Ticker Symbol Change to RDGL
January 02, 2018 09:00 ET
|
Vivos Inc.
Richland, WA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCPink: RDGL) announced today that it has changed its name to Vivos Inc., and that its shares are scheduled to...